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Nuclear magnetic resonance imaging has emerged in the
past few years as a completely noninvasive method for
medical imaging of internal organs. Because of the loss
of signal intensity by motional nuclei (hydrogen) using
most proton imaging techniques, flowing blood within
the cardiovascular system generates little or no signal
and consequently there is high natural contrast between
blood and the walls of blood vessels or cardiac chambers.
However, motion during imaging also complicates car-
diac imaging because signal is lost from the nuclei in the
moving cardiac structures. Consequently electrocardio-
graphic gating of data acquisition is required for nuclear
magnetic resonance imaging of the heart.
Distinct advantages of nuclear magnetic resonance
imaging in relation to other imaging modalities are good
contrast between soft tissues and the capability for char-
acterization of specific tissues by estimation of magnetic
relaxation times. Early in vitro studies measuring re-
Nuclear magnetic resonance imaging depicts organs and
tissues in relation to the interaction of their compositional
nuclei with a static magnetic field and fluctuating radio-
frequency pulses (l). As in ultrasound, the technique is
completely noninvasive; images of the cardiovascular sys-
tem are generated without the need for contrast media. Like-
wise, nuclear magnetic resonance imaging does not involve
ionizing radiation. Research to date reveals no important
genetic or somatic effects (2,3).
Imaging with nuclear magnetic resonance produces clear
discrimination between flowing blood and the vascular wall
because blood flowing in a laminar fashion at normal ve-
locities produces a low intensity or no nuclear magnetic
resonance signal (4-6). In contrast, the definition of vascular
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laxation times of myocardial tissue samples of excised
hearts indicate that nuclear magnetic resonance imaging
will be capable of discriminating infarcted from normal
myocardium. Recent studies using electrocardiograph-
ically gated nuclear magnetic resonance imaging of dogs
with acute infarction showed the infarct as a region of
high intensity on spin-echo images.
Initial clinical experience with electrocardiographi-
cally gated nuclear magnetic resonance imaging (0.35
tesla) in patients has clearly defined internal cardiac
anatomy without the use of contrast media. This tech-
nique has demonstrated the consequence of previous
myocardial infarction such as regional wall thinning,
aneurysm, thrombus and contractile dysfunction, a
number of pericardial abnormalities and the morphol-
ogy of hypertrophic and congestive cardiomyopathies.
(J Am Coil Cardiol/985;5:77S-8/S)
pathology by X-ray imaging techniques requires the use of
contrast media because the radiodensity of blood and the
vascular wall are so similar. The natural contrast between
flowing blood and the walls of the cardiac chamber and
great vessels suggests that nuclear magnetic resonance im-
aging might be very advantageous for defining cardiovas-
cular anatomy. An added advantage of such imaging is that
it can provide at least an estimate of flow velocity. Thus,
it seems capable of defining both anatomic and physiologic
abnormalities of the cardiovascular system. Through the
estimation of hydrogen density and the magnetic relaxation
rates of tissues (referred to as T I and T2 values), it is possible
to acheive tissue characterization (7,8). This latter capability
should be particularly important for the diagnosis and in-
vestigation of myocardial diseases.
Methodology for Cardiac Nuclear Magnetic
Resonance Imaging
The time required to obtain sufficient data to generate
nuclear magnetic resonance images encompasses several
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mimltes and hundreds of heartbeats. The continued motion
of the heart during the nuclear magnetic resonance pulse
sequence results in inadequate signal intensity and blurring
of the edges of moving structures such that diagnostic im-
ages of the heart are generally not obtained. Consequently,
synchronization of each radiofrequency pulse sequence to
a specific segment of the cardiac cycle is necessary to produce
images of the heart. We initially used three different phys-
iologic signals to gate nuclear magnetic resonance imaging
sequences; these have been described in an earlier report
(9). Because of predictable and constant timing of images
to specific segments of the cardiac cycle, electrocardio-
graphic gating has become the standard technique.
Gated nuclear magnetic resonance images were obtained
in normal volunteers and patients with a variety of cardiac
and myocardial disease. The nuclear magnetic resonance
imager (Diasonics, Inc.) used in this study was a super-
conducting magnet operating at 3.5 Kgauss, corresponding
to a hydrogen nucleus resonance frequency of 15 MHz. This
imager has been described previously in detail (10). The
images were obtained using spin-echo pulse sequences at
echo delay times of 28 and 56 ms; this is the delay between
application of the initiating radiofrequency pulse and receipt
of the spin-echo signal from the excited nuclei. At each,
two images were generated; one was formed from the first
spin-echo (TE = 28 ms) and the other using the second
echo (TE = 56 ms).
The repetition time ranged from approximately 0.6 to 1.2
seconds and was determined by the subject's heart rate. The
repetition time was equal to the RR interval of the electro-
cardiogram. To form images, radiofrequency and magnetic
field gradient pulses were applied in 512 cardiac cycles.
Total imaging time, a product of repetition time, the
number of lines along the y axis (vertical dimension of the
matrix) and the number of times the signal was averaged,
and ranged from approximately 5 to 10 minutes. Using the
multisection imaging technique, five adjacent 1 cm thick
slices were imaged by "fitting" five sections in the repe-
tition interval, with a 100 ms delay for each subsequently
irradiated section. Thus, the imaging period for all five
sections extended roughly over 500 ms. It should be noted
that with this technique, each slice is out of phase by 100
ms with the adjacent slice.
The nuclear magnetic resonance images were obtained
in a matrix of 128 vertical x 256 horizontal picture elements
and displayed in black and white, utilizing 256 gray shades,
where the brightest areas represent tissues with the highest
nuclear magnetic resonance signal. Each imaging plane had
a section thickness of 10 mm. The spatial resolution was
1.7 x 1.7 mm.
Current Experience
Normal cardiac anatomy. The electrocardiographi-
cally gated nuclear magnetic resonance images discretely
Figure 1. Gated nuclear magnetic resonance image through the
middle of the ventricles shows the internal structures of the ven-
tricles and clearly demonstrates the ventricular system. The right
coronary artery (arrow) is visualized lying within the fat of the
right atrioventricular groove. The nuclear magnetic resonance im-
ages produced from the first (left) and second (right) spin-echoes
are shown.
demonstrate internal cardiac morphology including the tra-
becular patterns of the right and left ventricles (Fig. I). The
chordal structures and papillary muscle of the left ventricle
and the moderator band of the right ventricle are visualized.
In normal patients, the pericardium is represented by a thin
rim of low signal intensity located over the ventral portion
of the heart (Fig. 2).
Signal intensity within the lumen of mediastinal vessels
Figure 2. Gated transverse nuclear magnetic resonance image.
The highest signal is produced by pericardial fat and fat in the
atrioventricular groove. The anterior pericardium is visualized as
a low intensity rim (arrow) between the subepicardial and sub-
sternal fat.
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Figure 3. Gated nuclear magnetic resonance image at the level
of the great vessels. This image gated to end-diastole shows high
signal intensity within the lumina of the superior vena cava, aorta
and pulmonary artery due to the low velocity of the flow during
this phase.
varies greatly depending on the phase of the cardiac cycle
used for gating. Images corresponding to systole generally
have no intraluminal signal, whereas images acquired in
diastolic show intense intraluminal signals (Fig. 3).
Left ventricular and myocardial abnormalities.
Nuclear magnetic resonance images have displayed regional
wall thinning of the left ventricle in patients with acute
myocardial infarction and wall thickening in patients with
left ventricular hypertrophy (Fig. 4). Gated nuclear mag-
Figure 4. Gated transverse nuclear magnetic resonance (NMR)
image through the mid portion of the left ventricle in a patient
with aortic stenosis and a right pericardial mass. The mass abuting
the right atrium produces moderate nuclear magnetic resonance
signal intensity. There is concentric wall thickening (hypertrophy)
of the left ventricle due to aortic stenosis.
Figure 5. Gated image in a patient with a prior anterior myocardial
infarction. There is thinning of the wall in the anterior portion of
the left ventricle. Note the moderator band of the right ventricle.
netic resonance images have displayed areas of extreme wall
thinning and bulging in patients with left ventricular an-
eurysms (Fig. 5). Left ventricular thrombus has been dem-
onstrated in several patients shown to have this abnormality
on either sector scan echocardiography or computed tom-
ographic scans.
Pericardial abnormalities. Pericardial effusions con-
sisting of pure pericardial fluid cause a region of low signal
intensity which displaces the parietal pericardium and per-
icardial fat away from the myocardial wall (Fig. 6). In
inflammatory forms of pericarditis, the pericardium and per-
icardial adhesions between the visceral and parietal peri-
Figure 6. Loculated pericardial effusion over right side of the
heart. Most of the effusion produces low signal but the intensity
of the effusion is nonhomogeneous.
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cardium show a dramatic change in the nuclear magnetic
resonance imaging characteristics. Instead of a low signal
caused by normal pericardium, they produce a relatively
high nuclear magnetic resonance signal intensity. Pericardial
cysts and paracardiac masses are clearly separated from the
heart on nuclear magnetic resonance images (Fig. 4).
Comparison With Noninvasive
Imaging Modalities
Advantages. Advantageous aspects of nuclear magnetic
resonance imaging are that there is no radiation and no
known genetic or biologic effects of the nuclear magnetic
resonance process at the field strengths currently being used
for imaging. It is completely noninvasive, requiring not even
venous catheterization or injection of any contrast media.
There is good spatial resolution and spatial separation of
regions of the heart with the tomographic format used with
nuclear magnetic resonance imaging. An additional advan-
tage is direct imaging along any plane of the body, that is,
axial, sagittal or coronal.
Limitations. The limitations of nuclear magnetic reso-
nance imaging at this time are the sampling frequency,
which is considerably less than is necessary for real time
assessment of valve motion and myocardial contraction. The
versatility of the imaging planes currently available are not
optimal for evaluating the cardiac valves. In comparison
with echocardiography, radionuclide scans and digital sub-
traction angiography, nuclear magnetic resonance imaging
is substantially more expensive and must provide additional
diagnostic information or safety to become clinically real-
istic. An additional concern for children is the 2 to 5%
incidence of claustrophobia encountered in the early clinical
experience with nuclear magnetic resonance imaging.
Future Perspectives
There is currently too little clinical experience with nu-
clear magnetic resonance imaging to predict with any re-
liance the eventual role of this technique in cardiovascular
diagnosis. However, it offers some intriguing possibilities
of insights of cardiovascular disease processes and their
response to therapeutic interventions, such as direct tissue
characterization, noninvasive regional blood flow measure-
ments and chemical and metabolic imaging.
Tissue characterization. The magnetic relaxation times
(T I and T2) of protons in different tissues are currently the
basis for tissue characterization (7,8). These relaxation times
and their diagnostic implications are poorly understood.
Nevertheless, many normal and abnormal tissues have been
shown to have combinations of T I and T2 values which fall
in a characteristic range for a specific tissue. These specific
relaxation times for various tissues have been estimated in
experimental animals and in human beings. Various disease
processes including ischemia have been found to alter the
magnetic relaxation times of tissues and organs (7,8).
Blood ftow measurement. It should be possible to quan-
titate blood flow noninvasively using nuclear magnetic res-
onance imaging. A number of techniques has been suggested
for quantitating flow with nuclear magnetic resonance (11,12),
including measurement of transit time of excited nuclei (II)
and the generation of "flow graphs" that plot the number
of nuclei flowing within various velocity intervals (12).
Metabolic imaging. Perhaps the most promising aspect
of nuclear magnetic resonance imaging is the potential for
metabolic imaging. This capability exploits another property
of nuclear magnetic resonance, the ability to measure chem-
ical shifts. The chemical nuclei (other than hydrogen) that
seem most attractive for in vivo chemical studies because
of a compromise among their nuclear magnetic resonance
sensitivity, abundance in biologic systems and biochemical
interest are sodium-23, carbon-I 3 and phosphorus-31. Most
of the current work on nuclear magnetic resonance spec-
troscopy of the myocardium in vivo has involved phospho-
rus-31. These phosphorus-31 nuclear magnetic resonance
spectroscopic studies have provided a method for monitor-
ing shifts in high energy phosphate and intracellular pH
during myocardial ischemia and with interventions intended
to attenuate the deleterious myocardial effects of ischemia
(13,14). This topic is discussed in greater detail in another
section of this conference.
References
I. Bradley W, Tosteson H. Basic physics of NMR. In: Kaufman L,
Crooks LE, Margulis AR, eds. Nuclear Magnetic Resonance Imaging
in Medicine. Tokyo: Igaku-Shoin, 1981:11-29.
2. Budinger TF, Cullander C. Biophysical phenomenon and health haz-
ards of in vivo magnetic resonance. In: Margulis AR, Higgins CB,
Kaufman L, Crooks LE, eds. Clinical Magnetic Resonance Imaging.
San Francisco: Radiology Research and Education Foundation, 1983:
303-20.
3. Wolff S, Crooks LE, Brown P, et al. Tests for DNA and chromosomal
damage induced by nuclear magnetic resonance imaging. Radiology
1980; 136:707.
4. Herfkens RJ, Higgins CB, Hricak H, et al. Nuclear magnetic resonance
imaging of the cardiovascular system: normal and pathologic findings.
Radiology 1983;147:749-59.
5. Kaufman L, Crooks L, Sheldon P, Hricak H, Herfkens R, Bank W.
The potential impact of nuclear magnetic resonance imaging on car-
diovascular diagnosis. Circulation 1982;67:251-7.
6. Kaufman L, Crooks LE, Sheldon PE, Rowan W, Miller T. Evaluation
of NMR imaging for detection and quantification of obstruction in
vessels. Invest Radiol 1982; 17:554-60.
7. Davis PL, Kaufman L, Crooks LE. Tissue characterization. In Ref 2:
53-9.
8. Higgins CB, Herfkens R, Lipton MJ, Seivers R, Sheldon P, Kaufman
L, Crooks LE. Nuclear magnetic resonance imaging of acute myo-
JACC Vol. 5, No.1
January 1985:77S-8! S
HIGGINS ET AL.
NUCLEAR MAGNETIC RESONANCE IMAGING
81S
cardial infarctions in dogs: alterations in magnetic relaxation times.
Am J Cardiol 1983;52:184-8.
9. Lanzer P, Lorenz V, Schiller NB, et al. Cardiac imaging using gated
nuclear magnetic resonance. Radiology 1984;150: 121-7.
10. Crooks LE, Arakawa M, Hoenninger J, et al. Nuclear magnetic res-
onance whole body imager operating at 3.5 KGauss. Radiology
1982;143:169-4.
II. Battocletti JH, Halback RE, Salles-Cunha SX, Sances A Jr. NMR
blood flowmeter-theory and history. Med Phys 1980;8:435-43.
12. Singer JR. Blood flow measurements by NMR. In Ref I: II, 128-44.
13. Nunally RL, Bottomley PA. 31p NMR studies of myocardial ischemia
and its response to drug therapies. J Comput Assist Tomogr 1981 ;5:296-
7.
14. Pernot AC, Ingwall JS, Menasche P, et al. Evaluation of high energy
phosphate metabolism during cardioplegic arrest and reperfusion: a
phosphorus-31 nuclear magnetic resonance study. Circulation
1983;67: 1296-305.
